智通财经APP获悉，维亚生物(01873)午后涨近15%，截至发稿，涨13.33%，报1.87港元，成交额1550.3万港元。
消息面上，万邦德与维亚生物近日达成AI创新药战略合作。双方将基于在化药、中药、AI等领域的优势，共育新质生产力，以AI赋能创新药研发。另外，双方也将在创新药布局、AI产业链布局、AI医药人才培养、全球BD等领域进行合作。
值得注意的是，维亚生物近日在"Enchantment of Drug Discovery"发布会上，首次展示了其自主研发的AIDD平台。招商证券此前指出，AI 赋能整个药物发现平台，从“AI辅助”向“AI驱动”发展。截止2024年底，AIDD 累计参与项目数157个，采购CADD/AIDD累计客户数51家，AI参与赋能的项目收入逾千万美元，并已在某些细分领域达成整套AI发现解决方案的知名合作。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.